GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION

被引：0
|
作者：
Balasus, D. [1 ]
Giannitrapani, L. [2 ]
Soresi, M. [2 ]
Vinciguerra, M. [3 ]
Marsha, M. [3 ]
Way, M. [3 ]
Licata, A. [2 ]
Cervello, M. [4 ]
Montalto, G. [2 ]
机构：
[1] Univ Palermo, Dept Sci & Biol Chem & Pharmaceut Technol SteBiCE, Palermo, Italy
[2] Univ Hosp Palermo, Biomed Dept Internal Med & Specialties DiBiMIS, Palermo, Italy
[3] UCL, Inst Liver & Digest Hlth, London, England
[4] Natl Res Council CNR, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, Italy
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60744-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P582
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [21] GRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients
    Winder, T.
    Bohanes, P.
    Zhang, W.
    Yang, D.
    Power, D. G.
    Ning, Y.
    Gerger, A.
    Wilson, P. M.
    Tang, L. H.
    Shah, M.
    Lee, A. S.
    Lenz, H. -J.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2431 - 2439
  • [22] Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis through GRP78
    Wang, Cun
    Jiang, Kai
    Gao, Dongmei
    Kang, Xiaonan
    Sun, Chun
    Zhang, Qinle
    Li, Yan
    Sun, Lu
    Zhang, Shu
    Guo, Kun
    Liu, Yinkun
    PLOS ONE, 2013, 8 (02):
  • [23] Silencing of Glucose-Regulated Protein 78 (GRP78) Enhances Cell Migration Through the Upregulation of Vimentin in Hepatocellular Carcinoma Cells
    Wei, Po-Li
    Kuo, Li-Jen
    Wang, Weu
    Lin, Feng-Yen
    Liu, Hui-Hsiung
    Tseng, How
    Ho, Yuan-Soon
    Huang, Ming-Te
    Wu, Chih-Hsiung
    Chang, Yu-Jia
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S572 - S579
  • [24] Silencing of Glucose-Regulated Protein 78 (GRP78) Enhances Cell Migration Through the Upregulation of Vimentin in Hepatocellular Carcinoma Cells
    Po-Li Wei
    Li-Jen Kuo
    Weu Wang
    Feng-Yen Lin
    Hui-Hsiung Liu
    Tseng How
    Yuan-Soon Ho
    Ming-Te Huang
    Chih-Hsiung Wu
    Yu-Jia Chang
    Annals of Surgical Oncology, 2012, 19 : 572 - 579
  • [25] Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
    Chang, Yu-Jia
    Chiu, Chong-Chi
    Wu, Chih-Hsiung
    An, Jane
    Wu, Cheng-Chia
    Liu, Tsan-Zon
    Wei, Po-Li
    Huang, Ming-Te
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) : 1703 - 1709
  • [26] Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma
    Yu-Jia Chang
    Chong-Chi Chiu
    Chih-Hsiung Wu
    Jane An
    Cheng-Chia Wu
    Tsan-Zon Liu
    Po-Li Wei
    Ming-Te Huang
    Annals of Surgical Oncology, 2010, 17 : 1703 - 1709
  • [27] CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population
    Wang, Da-dong
    Duan, Wei-dong
    Zhu, Zi-man
    Tu, Yu-liang
    Dou, Chun-qing
    Han, Ming-ming
    Zhang, Bao
    Zhao, Wei
    Jiang, Kai
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 : S516 - S518
  • [28] Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells
    Du, Haiyan
    Wu, Haochen
    Kang, Qinyang
    Liao, Mianmian
    Qin, Meirong
    Chen, Ning
    Huang, Houshuang
    Huang, Danping
    Wang, Ping
    Tong, Guangdong
    AGING-US, 2023, 15 (21): : 12251 - 12263
  • [29] Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78
    Jui-Ling Hsu
    Po-Cheng Chiang
    Jih-Hwa Guh
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2009, 380 : 373 - 382
  • [30] GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway
    Luo, Chenglin
    Xiong, Haixia
    Chen, Leifeng
    Liu, Xiuxia
    Zou, Shubing
    Guan, Jiafu
    Wang, Kai
    EXPERIMENTAL CELL RESEARCH, 2018, 365 (01) : 1 - 11
12345